Your browser doesn't support javascript.
loading
An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma.
Rodríguez Otero, Paula; Towle, Kevin; Cope, Shannon; Caisip, Clyde; Davies, Faith E; Delforge, Michel; Weisel, Katja; Marshall, Thomas S; Karampampa, Korinna; Ayers, Dieter; Mojebi, Ali; Braverman, Julia; Farrell, James; Dhanda, Devender.
Afiliación
  • Rodríguez Otero P; Clínica Universidad de Navarra, Pamplona, Spain.
  • Towle K; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
  • Cope S; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
  • Caisip C; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
  • Davies FE; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Delforge M; Department of Haematology, University Hospital Leuven, Leuven, Belgium.
  • Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.
  • Marshall TS; Bristol Myers Squibb, Princeton, NJ, USA.
  • Karampampa K; Bristol Myers Squibb, Uxbridge, UK.
  • Ayers D; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
  • Mojebi A; Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, Canada.
  • Braverman J; Bristol Myers Squibb, Princeton, NJ, USA.
  • Farrell J; Bristol Myers Squibb, Dublin, Ireland.
  • Dhanda D; Bristol Myers Squibb, Princeton, NJ, USA.
Leuk Lymphoma ; 64(11): 1864-1869, 2023.
Article en En | MEDLINE | ID: mdl-37497883

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: España